Vertex Pharmaceuticals (VRTX) Receivables - Net (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Receivables - Net of $2.13 billion for Q2 2026, up 12.7% from $1.89 billion a year earlier and up 6.9% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Receivables - Net (2009 - 2026) Analysis & Trends
At the end of FY2025, Vertex Pharmaceuticals' Receivables - Net came in at $2.05 billion, up 27.6% from FY2024.
- Annual Receivables - Net has increased for 11 consecutive years, with a five-year compound annual growth rate of 18.3% (FY2020 to FY2025).
- In prior years, Vertex Pharmaceuticals' Receivables - Net was $1.61 billion in FY2024 (+2.9%), $1.56 billion in FY2023 (+8.4%), $1.44 billion in FY2022 (+26.9%) and $1.14 billion in FY2021 (+28.4%).
- The Q2 2026 figure stands as the highest quarterly Receivables - Net in data going back to Q4 2009.
- On a year-over-year basis, Receivables - Net has increased in each of the last 46 quarters, with growth averaging 11.7% over the last eight quarters.
- Over the past five years, the year-over-year growth in Receivables - Net ranged from 0.7% (Q1 2025) to 43.5% (Q2 2022).
- According to Business Quant data, Receivables - Net for the three prior quarters was $2 billion (Q1 2026), $2.05 billion (Q4 2025) and $1.95 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.46 Bn | 1,101.04 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 614.45 Bn | 532.98 Bn | 17.26 Bn |
| 3 | AbbVie | 503.76 Bn | 476.87 Bn | 12.70 Bn |
| 4 | Merck | 367.67 Bn | 322.05 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.09 Bn | 262.08 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.81 Bn | 235.50 Bn | 12.86 Bn |
| 7 | Amgen | 236.49 Bn | 191.89 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.25 Bn | 165.45 Bn | 6.22 Bn |
| 9 | Pfizer | 170.18 Bn | 116.83 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 131.26 Bn | 103.26 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.13 Bn |
| Mar 31, 2026 | 2.00 Bn |
| Dec 31, 2025 | 2.05 Bn |
| Sep 30, 2025 | 1.95 Bn |
| Jun 30, 2025 | 1.89 Bn |
| Mar 31, 2025 | 1.81 Bn |
| Dec 31, 2024 | 1.61 Bn |
| Sep 30, 2024 | 1.75 Bn |
| Jun 30, 2024 | 1.66 Bn |
| Mar 31, 2024 | 1.79 Bn |
| Dec 31, 2023 | 1.56 Bn |
| Sep 30, 2023 | 1.54 Bn |
| Jun 30, 2023 | 1.56 Bn |
| Mar 31, 2023 | 1.55 Bn |
| Dec 31, 2022 | 1.44 Bn |
| Sep 30, 2022 | 1.39 Bn |
| Jun 30, 2022 | 1.33 Bn |
| Mar 31, 2022 | 1.29 Bn |
| Dec 31, 2021 | 1.14 Bn |
| Sep 30, 2021 | 1.10 Bn |
API Access
Vertex Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();